The western blotting indicated that Clcn3 deficiency may inhibit obesity through the AMPK-UCP1 axis, which could become a potential target for improving metabolic dysfunction and obesity. This evidence concerns the gene CLCN3 and obesity due to melanocortin 4 receptor deficiency.